欧康医药：证券事务代表任命公告

Group 1 - The company announced the appointment of Zhao Wenjing as the securities affairs representative, effective from September 1, 2025 [2] - The decision was made during the 11th meeting of the 4th Board of Directors [2] - The term of the appointment will last until the end of the current Board's term [2]